<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38929823</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Symptom Clusters in Acute SARS-CoV-2 Infection and Long COVID Fatigue in Male and Female Outpatients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">602</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14060602</ELocationID><Abstract><AbstractText>(1) Background: After an acute SARS-CoV-2 infection, patients are at risk of developing Long COVID, with fatigue as a frequent and serious health problem. Objectives: To identify symptom clusters in acute SARS-CoV-2 infections and investigate their associations with the development of Long COVID fatigue, and to examine sex-specific differences. (2) Methods: The analysis included a total of 450 COVID-19 outpatients, of whom 54.4% were female. The median ages of the men and women were 51 years (IQR 36.0; 60.0) and 48 years (IQR 33.0; 57.0), respectively. Data collection took place between November 2020 and May 2021, with a median time between acute SARS-CoV-2 infection and examination in the study center of 240 days (IQR 133; 326). The Fatigue Assessment Scale (FAS) was used to identify fatigue and its severity. A multiple correspondence analysis was used to group forty-two COVID-19 symptoms into seven symptom clusters. Logistic and log-linear regressions were used to investigate associations between acute symptom clusters and Long COVID fatigue as dichotomous and continuous outcome, respectively. (3) Results: Fatigue occurred more frequently in women than in men (45% vs. 25%) and the median FAS score, indicating severity of fatigue, was higher in women than in men. The comparison between men and women revealed notable differences in four out of seven clusters. The strongest associations between symptom clusters in infection and Long COVID fatigue were identified for the cluster "cognitive and mental symptoms". In the log-linear regression model, each additional symptom in this cluster was associated with an increase of the FAS score by 5.13% (95% CI: [0.04; 0.07]; <i>p</i> &lt; 0.001). The results of the logistic regression models supported this finding. Each additional symptom in this symptom cluster increased the odds of fatigue by 42% (95% CI: [1.23; 1.66]; <i>p</i> &lt; 0.001). (4) Conclusions: In our study in COVID-19 outpatients, a strong association was observed between the number of symptoms in the cluster "cognitive and mental symptoms" during acute SARS-CoV-2 infection and the risk of developing fatigue months later. The consequent use of preventive and therapeutic strategies is necessary to decrease the burden of fatigue in the context of Long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Vincenza</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-3954-2256</Identifier><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freuer</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7188-9087</Identifier><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Go&#xdf;lau</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9522-5864</Identifier><AffiliationInfo><Affiliation>Clinic for Vascular Surgery, Medical Faculty, University Hospital, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchberger</LastName><ForeName>Inge</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1967-709X</Identifier><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warm</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0114-2425</Identifier><AffiliationInfo><Affiliation>Clinic for Vascular Surgery, Medical Faculty, University Hospital, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyhlik-D&#xfc;rr</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinic for Vascular Surgery, Medical Faculty, University Hospital, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meisinger</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linseisen</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9386-382X</Identifier><AffiliationInfo><Affiliation>Epidemiology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Information Processing, Biometry and Epidemiology-IBE, Marchionistra&#xdf;e 15, 81377 Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NA</GrantID><Agency>Bavarian state funding for SARS-CoV-2 research projects 2020</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">acute COVID-19 symptom clusters</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">outpatients</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38929823</ArticleId><ArticleId IdType="pmc">PMC11205233</ArticleId><ArticleId IdType="doi">10.3390/jpm14060602</ArticleId><ArticleId IdType="pii">jpm14060602</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koczulla A., Ankermann T., Behrends U., Berlit P., Brinkmann F., Frank U., Gl&#xf6;ckl R., Gogoll C., H&#xe4;user W., Hohberger B., et al.  S1-Leitlinie Long/Post-COVID [S1 Guideline]. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) e. V.; 2023.  [(accessed on 3 May 2023)].  Available online:  https://register.awmf.org/de/leitlinien/detail/020-027.</Citation></Reference><Reference><Citation>RKI Hinweise zur Testung von Patientinnen und Patienten auf SARS-CoV-2: Robert Koch-Institut; 2023.  [(accessed on 20 December 2023)].  Available online:  https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Vorl_Testung_nCoV.html?nn=13490888#doc13490982bodyText1.</Citation></Reference><Reference><Citation>O&#x2019;Mahoney L.L., Routen A., Gillies C., Ekezie W., Welford A., Zhang A., Karamchandani U., Simms-Williams N., Cassambai S., Ardavani A., et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine. 2023;55:101959. doi: 10.1016/j.eclinm.2023.101959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101959</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi M.S., Omrani O.A., Fawzy N.A., Shaar B.A., Almamlouk R., Riaz M., Obeidat M., Obeidat Y., Gerberi D., Taha R.M., et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine, National Academies Press (US); Washington, DC, USA: 2015. The National Academies Collection: Reports funded by National Institutes of Health.</Citation></Reference><Reference><Citation>Norheim K.B., Jonsson G., Omdal R. Biological mechanisms of chronic fatigue. Rheumatology. 2011;50:1009&#x2013;1018. doi: 10.1093/rheumatology/keq454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keq454</ArticleId><ArticleId IdType="pubmed">21285230</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk C.G., Peterson D., Armstrong J., Knox K., Roy A. Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases. Infect. Agents Cancer. 2023;18:7. doi: 10.1186/s13027-023-00485-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-023-00485-z</ArticleId><ArticleId IdType="pmc">PMC9902840</ArticleId><ArticleId IdType="pubmed">36750846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo J.A., Mart&#xed;nez-L&#xf3;pez J.P., Carrillo-Lamp&#xf3;n S.A., Ruiz-Ojeda D., Herrera-Ram&#xed;rez S., Amezcua-Guerra L.M., Mart&#xed;nez-Alvarado M.d.R. Post-Acute COVID-19 Symptoms, a Potential Link with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A 6-Month Survey in a Mexican Cohort. Brain Sci. 2021;11:760. doi: 10.3390/brainsci11060760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) National Institute for Health and Care Excellence: Guidelines. National Institute for Health and Care Excellence (NICE); London, UK: 2021. Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management.</Citation></Reference><Reference><Citation>Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study. Int. J. Environ. Res. Public Health. 2021;18:2030. doi: 10.3390/ijerph18042030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18042030</ArticleId><ArticleId IdType="pmc">PMC7921928</ArticleId><ArticleId IdType="pubmed">33669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  COVID-19 Weekly Epidemiological Update: World Health Organization. 2021.  [(accessed on 11 May 2021)].  Available online:  https://iris.who.int/bitstream/handle/10665/341329/CoV-weekly-sitrep11May21-eng.pdf?sequence=1.</Citation></Reference><Reference><Citation>Sabes-Figuera R., McCrone P., Hurley M., King M., Donaldson A.N., Ridsdale L. The hidden cost of chronic fatigue to patients and their families. BMC Health Serv. Res. 2010;10:56. doi: 10.1186/1472-6963-10-56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-10-56</ArticleId><ArticleId IdType="pmc">PMC2845126</ArticleId><ArticleId IdType="pubmed">20202216</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidbauer L., Kirchberger I., Go&#xdf;lau Y., Warm T.D., Hyhlik-D&#xfc;rr A., Linseisen J., Meisinger C. The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting. J. Neurol. 2023;270:3294&#x2013;3302. doi: 10.1007/s00415-023-11752-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11752-9</ArticleId><ArticleId IdType="pmc">PMC10204671</ArticleId><ArticleId IdType="pubmed">37219607</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries J., Michielsen H.J., Van Heck G.L. Assessment of fatigue among working people: A comparison of six questionnaires. Occup. Environ. Med. 2003;60:i10&#x2013;i15. doi: 10.1136/oem.60.suppl_1.i10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.60.suppl_1.i10</ArticleId><ArticleId IdType="pmc">PMC1765720</ArticleId><ArticleId IdType="pubmed">12782741</ArticleId></ArticleIdList></Reference><Reference><Citation>Michielsen H.J., De Vries J., Van Heck G.L. Psychometric qualities of a brief self-rated fatigue measure. J. Psychosom. Res. 2003;54:345&#x2013;352. doi: 10.1016/S0022-3999(02)00392-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(02)00392-6</ArticleId><ArticleId IdType="pubmed">12670612</ArticleId></ArticleIdList></Reference><Reference><Citation>How to Use the Fatigue Assessment Scale (FAS)?: Interstitial Lung Disease Care Foundation. 2015.  [(accessed on 9 September 2022)].  Available online:  https://www.ildcare.nl/index.php/how-to-use-the-fas-fatigue-assessment-scale/</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen A., Castro A.W., Ferretti M.T., Martinkova J., Vasilevskaya A., Santuccione Chadha A., Tartaglia M.C. Sex and gender differences in the neurological and neuropsychiatric symptoms of long COVID: A narrative review. Ital. J. Gend. -Specif. Med. 2022;8:18&#x2013;28.</Citation></Reference><Reference><Citation>Sylvester S.V., Rusu R., Chan B., Bellows M., O&#x2019;Keefe C., Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: A review. Curr. Med. Res. Opin. 2022;38:1391&#x2013;1399. doi: 10.1080/03007995.2022.2081454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., Ernst K.C., Jacobs E.T., Klimentidis Y.C., Jehn M., Pogreba-Brown K. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS ONE. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo M.D.M., Foppiani A., Peretti G.M., Mangiavini L., Battezzati A., Bertoli S., Martinelli Boneschi F., Zuccotti G.V. Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort Study. Open Forum Infect. Dis. 2021;8:ofab384. doi: 10.1093/ofid/ofab384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab384</ArticleId><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Pinto M.D., Borelli J.L., Asgari Mehrabadi M., Abrahim H.L., Dutt N., Lambert N., Nurmi E.L., Chakraborty R., Rahmani A.M., et al. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic. Clin. Nurs. Res. 2022;31:1390&#x2013;1398. doi: 10.1177/10547738221125632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10547738221125632</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Florencio L.L., Navarro-Pardo E., Rodr&#xed;guez-Jim&#xe9;nez J., Torres-Macho J., Pellicer-Valero O.J. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2023;51:61&#x2013;69. doi: 10.1007/s15010-022-01822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., Ward H., Elliott P. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv. 2021 medRxiv:2021.06.28.21259452.</Citation></Reference><Reference><Citation>Dixon B.E., Wools-Kaloustian K.K., Fadel W.F., Duszynski T.J., Yiannoutsos C., Halverson P.K., Menachemi N. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study. PLoS ONE. 2021;16:e0241875. doi: 10.1371/journal.pone.0241875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241875</ArticleId><ArticleId IdType="pmc">PMC7990210</ArticleId><ArticleId IdType="pubmed">33760821</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Lee K.A., Ni Lochlainn M., Varsavsky T., Murray B., Graham M.S., Menni C., Modat M., Bowyer R.C.E., Nguyen L.H., et al. Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app. Sci. Adv. 2021;7:eabd4177. doi: 10.1126/sciadv.abd4177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd4177</ArticleId><ArticleId IdType="pmc">PMC7978420</ArticleId><ArticleId IdType="pubmed">33741586</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Mora J.A., Gonz&#xe1;lez A., Jim&#xe9;nez-Morgan S., Cordero-Laurent E., Brenes H., Soto-Garita C., Sequeira-Soto J., Duarte-Mart&#xed;nez F. Clinical Profiles at the Time of Diagnosis of SARS-CoV-2 Infection in Costa Rica During the Pre-vaccination Period Using a Machine Learning Approach. Phenomics. 2022;2:312&#x2013;322. doi: 10.1007/s43657-022-00058-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43657-022-00058-x</ArticleId><ArticleId IdType="pmc">PMC9173838</ArticleId><ArticleId IdType="pubmed">35692458</ArticleId></ArticleIdList></Reference><Reference><Citation>RKI  SARS-CoV-2: Virologische Basisdaten Sowie Virusvarianten im Zeitraum von 2020&#x2013;2022 Robert Koch-Institut (RKI) 2023.  [(accessed on 21 September 2023)].  Available online:  https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Virologische_Basisdaten.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>